ACC - Atrial Contribution to CRT
- Conditions
- Dilated Cardiomyopathy
- Interventions
- Device: Renewal
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2021-02-11
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 43
- Registration Number
- NCT00180323
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
Safety and Efficacy Study of RENEWAL 4 AVT
- Conditions
- Heart FailureTachycardiaAtrial FibrillationAtrial FlutterVentricular Fibrillation
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2007-06-25
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 170
- Registration Number
- NCT00180336
- Locations
- 🇩🇪
Kerckhof Klinik, Bad Nauheim, Germany
SITELINE 2 Polyurethane
- Conditions
- Bradycardia
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2011-09-29
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT00180284
- Locations
- 🇺🇸
Multiple Locations in the United States, St. Paul, Minnesota, United States
Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ?
- Conditions
- Cardiac Arrest
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT00180362
- Locations
- 🇩🇪
Allg. Krankenhaus St. Georg, Hamburg, Germany
Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead
- Conditions
- Ventricular TachycardiaVentricular Fibrillation
- Interventions
- Device: Endotak Reliance G
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 215
- Registration Number
- NCT00180297
- Locations
- 🇫🇷
CH Amiens, Amiens, France
🇫🇷CHU Angers, Angers, France
🇫🇷CH Besancon, Besancon, France
Leader - Evaluation of Endotak Reliance
- Conditions
- Ventricular FibrillationVentricular Tachycardia
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-04-14
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 904
- Registration Number
- NCT00180349
- Locations
- 🇫🇷
CH Amiens, Amiens, France
🇫🇷CHU Angers, Angers, France
🇫🇷Hôpital Angoulème, Angoulème, France
MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms
- Conditions
- Heart Failure
- Interventions
- Behavioral: CRT-P and CRT-D devices
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT00180401
- Locations
- 🇩🇪
Klinikum der Christian Albrecht Universität / Kardiologische Abteilung, Kiel, Germany
MODULA Modul 7 VRR
- Conditions
- Atrial Fibrillation
- Interventions
- Device: CRT devices with ventricular rate regulation [VRR] (CE labeled)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 8
- Registration Number
- NCT00180414
- Locations
- 🇩🇪
Klinikum Lüdenscheid / Kardiologie, Luedenscheid, Germany
PACMAN - PAcing for CardioMyopathies, a EuropeAN Study
- Conditions
- Heart Failure
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 262
- Registration Number
- NCT00180596
- Locations
- 🇧🇪
Guidant Corporation, , , Belgium, Diegem, Belgium
🇩🇪Medizinische Klinik I, University RWTH Aachen, Aachen, Germany
OPERA: French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator
- Conditions
- Ventricular TachycardiaVentricular Fibrillation
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 636
- Registration Number
- NCT00180375
- Locations
- 🇫🇷
CHG Aix en Provence, Aix en Provence, France
🇫🇷CHG Albi, Albi, France
🇫🇷CH Amiens, Amiens, France